Mixed Topics
From the Journals
New angiotensin studies in COVID-19 give more reassurance
A deluge of new data does not suggest harm with ACE inhibitors and angiotensin blockers in COVID-19 rates or outcomes.
From the Journals
Multisociety roadmap eyes restarting elective cardiac cases
From the Journals
Hydroxychloroquine-triggered QTc-interval prolongations mount in COVID-19 patients
From the Journals
Out-of-hospital cardiac arrests soar during COVID-19 in Italy
Conference Coverage
COVID-19: A ‘marathon, not a sprint’ for psychiatry
Providing emotional support will help individuals engage with instrumental supports, said Dr. Joshua Morganstein.
Feature
New study of diabetes drug for COVID-19 raises eyebrows
Feature
Survey: Hydroxychloroquine use fairly common in COVID-19
Conference Coverage
COVID-19: No U.S. spike expected in pandemic-related suicidal ideation
Big Data analysis of real-time Crisis Text Line experience offers encouragement.
Conference Coverage
COVID-19: Calls to NYC crisis hotline soar
Inbound call volume has increased roughly 50% since the COVID-19 pandemic hit.
From the Journals
Consensus recommendations on AMI management during COVID-19
The ACC, ACEP, and SCAI recommend a systematic approach for the care of patients with an acute myocardial infarction during the COVID-19 pandemic...
News
Visa worries besiege immigrant physicians fighting COVID-19
Hospital leaders call for flexibility to keep immigrant physicians on the front lines of the COVID-19 battle.